Mark Grove - Forian VP Sales
| FORA Stock | USD 2.02 0.14 6.48% |
Insider
Mark Grove is VP Sales of Forian Inc
| Address | 41 University Drive, Newtown, PA, United States, 18940 |
| Phone | 267 225 6263 |
| Web | https://forian.com |
Forian Management Efficiency
The company has return on total asset (ROA) of (0.0632) % which means that it has lost $0.0632 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0563 %, meaning that it created $0.0563 on every $100 dollars invested by stockholders. Forian's management efficiency ratios could be used to measure how well Forian manages its routine affairs as well as how well it operates its assets and liabilities. At present, Forian's Return On Tangible Assets are projected to increase based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.20, whereas Return On Capital Employed is projected to grow to (0.10). At present, Forian's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 5.5 M, whereas Total Assets are forecasted to decline to about 38.4 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jona Raasch | National Research Corp | 65 | |
| Jason Jones | Health Catalyst | N/A | |
| Gregory MS | National Research Corp | N/A | |
| Kate Jensen | Definitive Healthcare Corp | 38 | |
| Jon Boumstein | National Research Corp | N/A | |
| Paul Horstmeier | Health Catalyst | 63 | |
| Joseph Mirisola | Definitive Healthcare Corp | 40 | |
| Patrick Nelli | Health Catalyst | N/A | |
| Justin Steinman | Definitive Healthcare Corp | N/A | |
| Jon Maack | Definitive Healthcare Corp | N/A | |
| Robert JD | Definitive Healthcare Corp | 54 | |
| Tyson Murdock | HealthEquity | 53 | |
| Daniel Burton | Health Catalyst | 49 | |
| CPA CPA | National Research Corp | 66 | |
| Richard Booth | Definitive Healthcare Corp | 55 | |
| Tom Penque | Definitive Healthcare Corp | N/A | |
| Scott Oberlink | Definitive Healthcare Corp | N/A | |
| Helen Hrdy | National Research Corp | 59 | |
| Dave Ross | Health Catalyst | N/A | |
| David Kronfeld | Definitive Healthcare Corp | N/A | |
| Jason Alger | Health Catalyst | 40 | |
Management Performance
| Return On Equity | 0.0563 | ||||
| Return On Asset | -0.0632 |
Forian Inc Leadership Team
Elected by the shareholders, the Forian's board of directors comprises two types of representatives: Forian inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Forian. The board's role is to monitor Forian's management team and ensure that shareholders' interests are well served. Forian's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Forian's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Terrell, BioTrack Officer | ||
| Jason Holden, Vice Development | ||
| Edward Spaniel, General VP | ||
| Andrew Douglas, Chief Officer | ||
| Daniel Barton, CEO Director | ||
| Rebecca Adams, Vice Resources | ||
| Michael Vesey, Chief Officer | ||
| Paul Reuscher, Chief Officer | ||
| Max Wygod, CoFounder Chairman | ||
| Adam Dublin, Chief CoFounder | ||
| Mark Grove, VP Sales |
Forian Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Forian a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0563 | ||||
| Return On Asset | -0.0632 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | (0.42) % | ||||
| Current Valuation | 42.03 M | ||||
| Shares Outstanding | 31.02 M | ||||
| Shares Owned By Insiders | 52.12 % | ||||
| Shares Owned By Institutions | 13.69 % | ||||
| Number Of Shares Shorted | 146.7 K | ||||
| Price To Book | 2.49 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Forian Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Forian's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Forian Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Forian Inc Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forian Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Forian. If investors know Forian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Forian listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 0.649 | Quarterly Revenue Growth (0.02) | Return On Assets (0.06) | Return On Equity 0.0563 |
The market value of Forian Inc is measured differently than its book value, which is the value of Forian that is recorded on the company's balance sheet. Investors also form their own opinion of Forian's value that differs from its market value or its book value, called intrinsic value, which is Forian's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Forian's market value can be influenced by many factors that don't directly affect Forian's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Forian's value and its price as these two are different measures arrived at by different means. Investors typically determine if Forian is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Forian's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.